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Summary 
Analyses  of the relationships between different viruses and viral proteins have focused  on homologies 
between linear amino acid sequences, but cross-reactivities at the level of T cell recognition may 
not be dependent on a conserved linear sequence of several amino acids. The CTL response to 
Pichinde  virus (PC) and vaccinia virus  (VV)  in C57BL/6  mice previously immunized with 
lymphocytic choriomeningitis virus (LCMV) included the reactivation of memory cytotoxic T 
lymphocyte (CTL) specific to LCMV. Limiting dilution assays (LDA) demonstrated that at least 
part of this reactivation of memory cells in LCMV-immune mice related to cross-reactivity at 
the clonal level, even though acute infections with these viruses in nonimmune mice elicited 
CTL responses that did not cross-react in conventional bulk CTL assays. Precursor CTL (pCTL) 
to LCMV were generated in splenic leukocytes from LCMV-immune mice acutely infected with 
PV or W  when stimulated in vitro with only the second virus but not with uninfected peritoneal 
exudate cells (PECs). Cytotoxicity mediated by l.CMV-specific  CTL clones activated  by PV infection 
was greatly inhibited by anti-CD8 antibody, suggesting that these memory  CTL clones recognizing 
LCMV-infected targets were of  low affinity. LCMV-immune splenocytes stimulated in vitro with 
FV or W  demonstrated a low but significant precursor frequency (p/f) to the heterologous viruses, 
and splenocytes  from PV- or W-immune mice when stimulated in vitro against I_CMV generated 
a low but significant p/f to LCMV. Short-term CTL dones cross-reactive between LCMV and 
FV were derived from splenic leukocytes from LCMV-immune mice acutely infected with PV. 
To distinguish whether the cross-reactivity was directed against a viral peptide or a virus-induced 
endogenous cellular neoantigen, we demonstrated that a pCTL frequency to PV about 1/4-1/7 
that of the frequency to LCMV could be generated from LCMV-immune splenic leukocytes 
stimulated with the immunodominant LCMV NP peptide. A partially homologous PV peptide 
generated from the equivalent site to the LCMV NP peptide did not sensitize targets to lysis 
by either LCMV- or PV-specific CTLs,  suggesting that the cross-reactivity in killing was not 
due to evolutionarily  conserved  equivalent sequences.  Experiments also indicated that prior immunity 
to one virus could modulate future primary immune responses to a second virus. Elevated pCTL 
frequencies to PV were seen after acute FV infection of LCMV-immune mice, and elevated pCTL 
frequencies to LCMV were seen after acute LCMV infection of PV- and W-immune mice. The 
implication of these analyses  is that, at the T cell level, there may be a great deal of immunological 
cross-reactivity between heterologous viruses, and by virtue of this proposed remote T cell cross- 
reactivity, the host's response to a virus infection may be modified by its previous experience 
with other putatively unrelated  pathogens. 
nalyses of the relationships between viruses have focused 
on homologies in nucleotide or amino acid sequences. 
Sharing of a linear sequence of amino acids between different 
viral proteins can result in serological  cross-reactivities,  leading 
to cross-protective immunity. Selective pressure at the level 
of viral neutralization  has led to high variation of virion sur- 
face proteins between virus species, and it is this lack of  cross- 
reactivity at the level of neutralizing antibodies that is used 
as a major criterion for identifying distinct virus species. Cross- 
reactivities at the level of T cell recognition may be altogether 
different and much less dependent on a conserved linear se- 
quence of several amino acids. Some studies analyzing im- 
munodominant epitopes of infectious agents have found that 
apparently unrelated peptides from the same or a heterolo- 
gnus virus can sensitize a target cell to the same CTL line 
or clone (1-4). Analyses of the amino acid sequences of these 
peptides have shown relatively little amino acid homology, 
with the exception that the peptides needed to comply with 
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therefore sometimes shared identical amino acids in two or 
three positions of the peptide nonamer (5). The implication 
of these analyses is that, at the T  cell level, there may be a 
great deal of immunological cross-reactivity between sero- 
logically distinct viruses. 
We have been analyzing the specificities  and cross-reactixa'ties 
of CTL induced in mice by LCMV, which elicits a profound 
polyclonal CD8 + CTL response  associated  with a  10-40- 
fold  increase  in  total  number  of  activated  proliferating 
CD8 + T  cells/spleen  (6).  The vast majority of these cells 
display activation markers such as the IL-2R (CD25) (7), the 
memory cell marker Pgp-1 (CD44) (8) and the adhesion mol- 
ecule and memory marker Mac-1  (CDllb) (9),  and at least 
25% of the cells have the large granular lymphocyte mor- 
phology of cytotoxic effectors (10). Part of the CTL response 
consists of allospecific CTL detectable in primary bulk assays 
and specific for cells expressing a wide variety of alloantigens 
(6, 11, 12). Limiting dilution assay (LDA)  1 analyses demon- 
strated many aUospecific CTL dones cross-reactive with virus- 
infected syngeneic targets. This induction of allospecific CTL 
also occurred in mouse infections with vaccinia virus (VV), 
Pinchinde virus (PV), and murine cytomegalovirus (MCMV) 
(11, 12), and in the human during acute EBV infection (13, 14). 
A second observation was that in lymphocytic  choriomeni- 
gitis virus (LCMV)-hyperimmune mice, i.e., mice challenged 
with I.CMV one to two times after original infection, a por- 
tion of the CTL response elicited during acute infection with 
a second virus (PV, VV,  or MCMV) consisted of memory 
CTLs specific for the first virus, LCMV (12). The present 
study demonstrates that these LCMV-specific CTLs are easily 
detectable in mice having received a single LCMV infection 
and later challenged with a heterologous viral infection (PV, 
VV). Analogous to the allospecific CTL at the donal level, 
an unexpectedly large portion of these LCMV-specific CTLs 
were cross-reactive with MHC-syngeneic target cells infected 
with the second virus. In addition, a history of  LCMV infec- 
tion caused a more vigorous CTL response to either PV or VV. 
This study demonstrates that there may be much greater 
than anticipated immunological cross-reactivity at the T cell 
level between viruses that are serologically unrelated and that 
such cross-reactivity may be of significance in one's "natural" 
resistance  to subsequent infections with unrelated viruses. 
Mat~riah and Methods 
M/ce.  The C57BL/6  (H-2  b) mice were purchased from The 
Jackson Laboratories (Bar Harbor, ME). Mice were used at 1-6 
mo of age, 
Viruses.  The  LCMV  Armstrong  strain  was  propagated in 
BHK21 baby hamster kidney cells (15). The WK strain of  W  and 
the AN3739 strain of IN, an arenavirus only distantly related to 
LCMV, were propagated in L929 cells (16). Mice were injected in- 
1 Abbreviations used in this paper: LCMV, lymphocytic  choriomeningitis 
virus; LDA, limiting dilution assay; MCMV, routine cytomegalovirus; 
NP, nucleoprotein;  pCTL,  precursor CTL; PEC, peritoneal  exudate  cell; 
p/f, precursor frequency;  PV, Pichinde  virus; VV, vacdnia  virus. 
traperitoneally  with 4 x  104 PFU of LCMV, 7 x  106 PFU of W, 
or 106 PFU of PV in 0.1 ml vol/mouse for acute virus infection. 
Cell Lines.  KO cells (H-2b), a SV40-transformed kidney cell 
line derived from a C57BL/6 mouse (17) and provided to us by 
Dr. Satvir Tevethia (Pennsylvania  State Medical Center, Hershey, 
PA), were propagated in DMEM (Gibco Laboratories, Grand Is- 
land, NY) supphmented with 100 U/m1 penidllin G, 100 #g/m1 
streptomycin sulfate, 2 mM L-glutamine, 5  ￿  10-s M 2-ME, 10 
mM Hepes, and 10% heat inactivated (56~  30 rain) FBS (Sigma 
Chemical Co., St. Louis, MO). L929 (H-2~), a continuous liver 
cell line  derived  from  C3H  mice,  and  MC57G  (H-2b),  a 
methylcholanthrene-induced  fibrobhst cell  line from C57BL/6 mice, 
were propagated  in Eagle's  MEM (Gibco  Laboratories)  supplemented 
with 100 U/m1 penicillin  G, 100 #g/m1 streptomycin  sulfate,  2 mM 
L-glutamine,  and 10% heat inactivated  FBS. KO and MC57G cells 
were infected  with LCMV or IN at a multiplicity  ofinfi~on (MOI) 
of  0.1-0.2 PFU/cell and incubated for 2 d at 37~  KO ceils were 
infected with W  at a MOI of 4 for 3-4 h at 37~ 
Depletion of NK Cells In Vim.  Antiserum to asialo GM1 (5 #1; 
Wako Chemical, Dallas, TX) was injected intraperitoneally in a 
volume of 0.1 ml, on days 0 and 4 of acute infection. In immune 
mice not receiving a second viral infection, the antibody was given 
2 d before the harvesting of spleens. As the asialo GMI antigen 
can be expressed on some T cells (18, 19), we carefully titrated 
every lot to obtain a concentration of antiserum that selectively 
reduces NK cell activity without affecting CTL activity. This 
regimen of antibody nearly completely depleted NK cell activity 
for at least an 8-d time period. 
Cytotoxicity  Assays.  Ceil-mediated  cytotoxicity  was determined 
using a standard microcytotoxidty (CTL) assay  (16). KO cells (1-3 
x  106) were pelleted, resuspended in 0.2 ml of Na-SlCr (Amer- 
sham Corp., Arlington Heights, IL), and incubated for 1 h at 37~ 
in a humidified 5% COs incubator. They were rinsed three times 
and resuspended to 5 x  10~/ml, and 0.1 ml was added to round- 
bottomed microtiter wells (Falcon  Labware,  Oxnard, CA). Varying 
numbers of effector leukocytes were added in triplicate in 0.1 ml 
of medium to achieve  the desired E/T ratio. For spontaneous SlCr 
release controls, 0.1 ml of media was added to the labeled target 
cells in place of effectors. For maximum SlCr-release control, 0.1 
ml ofi% NP-40 (United States Biochemical  Co., Cleveland,  OH) 
was added to the labeled target cells. After 6-8 h at 37~  in a 5% 
COs incubator, the microtiter plates were centrifuged at 200 g for 
5 min.  Supematant was removed (0.1 ml) from each well and 
counted on a gamma counter (model 5000; Beckman Instruments, 
Inc., Fullerton, CA). Data are expressed as percent spedfic SlCr 
release =  100  x  [(experimental  cpm -  spontaneous cpm)/(max- 
imum release cpm  -  spontaneous release cpm)]. 
LDAfor Virus-specific CTL Precursors.  The assays  used the pro- 
cedure of Moskophidis et al. (20) with modifications  as previously 
described (6). Briefly,  splenic  lymphocytes were harvested, titrated 
in U-96-weU plates with 24 replicates  at each tritration. They were 
stimulated with virus infected peritoneal exudate cells (PECs) (3 
x  104/well),  supplemented with irradiated splenic feeders (1-2 x 
10  s/well) and growth factors provided by using a 16% culture su- 
pernatant from the IL-2-secreting, gibbon lymphoma tumor cell 
line MLA.144 (American  Type  Culture Collection, Rockville,  MD) 
(21). These studies were routinely done with splenocytes  isohted 
from mice depleted of NK cells by antiserum to asialo GM1 in 
order to minimize NK ceil outgrowth in the LDA. This treatment 
did not significantly  alter the frequency  of the LCMV-specific  CTL 
precursors. In our earlier report we showed that the LCMV-specific 
CTL precursors were CD8 + ceils (6). 
In the case of W, which was a highly lytic virus in vitro, an 
1934  Cross-reactive  CTLs between Heterologous  Viruses alternate method was used. The thioglycollate-injected mice were 
also injected with 7  x  106 PFU of VV in 0.1 ml i.p. 12 h before 
plating. The isolated PEC were then plated at 3  x  104 cells/well 
in 50/xl of media, and neutralizing  polyclonal rabbit  antiserum 
to W  was added at 1/50 dilution  final concentration  (22). On 
days 5-8 of culture,  individual wells were split threefold and as- 
sayed for cytolytic function  on infected and uninfected syngeneic 
target cells (KO) using a modified stCr release assay. SlCr-labeled 
targets (5  x  103)  were added to all wells to a final volume of 200 
/~l/well. The plates were incubated 9-10 h at 37~  in a 5% CO2 
incubator, centrifuged  for 5 min at 130 g (IEC C1LU-5000 cen- 
trifuge;  International  Equipment  Co., Needham  Heights,  MA), 
and 0.1 ml of supernatant was harvested. Positive wells were defined 
as those wells whose S:Cr release exceeded the mean spontaneous 
release by >3 SD. All wells that lysed uninfected syngeneic targets 
tested were eliminated from the analysis. Frequencies were calcu- 
lated using X  2 analysis according to Taswell (23) on a computer 
program kindly provided by Dr.  Richard Miller (University  of 
Michigan,  Ann Arbor,  MI). 
Anti-CD8 Blocking and Complement Depletion of CTL.  Anti- 
CD8 produced by hybridoma M12/7.2, well-documented to block 
CTL-mediated lysis, was kindly provided by Dr. Eric Martz (Univer- 
sity of Massachusetts, Amherst,  MA) (6). A 1:160 final dilution 
of an NH4SO4 cut of the hybridoma culture fluid was added to 
the LDA effector cells for I h before adding the targets on the day 
of the cytotoxicity assay. Splenocytes were depleted of CD8 § cells 
with antibody and rabbit complement as previously described (12). 
NP-peptide Stimulation in LDAs.  LCMV H-2  b restricted  im- 
munodominant nudeoprotein (NP) peptide (QPQNGQFIHFY) 
(5) was synthesized by Dr. Robert Carraway (University of Mas- 
sachusetts Medical Center). These peptides were purified to >95% 
homogeneity by reverse-phase  HPI.C. LDAs were set up as described 
above with the following exceptions: PECs were pulsed for 0.5 h 
with the peptide at 100 ~tM concentration  and then placed in the 
LDA (100/~l/well). All media used in the LDA were the same as 
above except that they contained IL-7 (Genzyme Corp., Cambridge, 
MA) at 15 U/ml. 
Results 
Viral Infections Activate CTL Specific  for Viruses  from Previous 
Infections.  C57BL/6 mice were inoculated with LCMV to 
generate a pool of LCMV-specific memory T  cells and used 
in experiments 1-4 mo later. These are referred to as LCMV- 
immune mice. As can be seen in Figs. 1 (day 5 post infection) 
and 2 (day 7 post acute infection),  spleen leukocytes from 
uninfected control or from LCMV-immune  mice failed to 
lyse significantly any of the targets  tested,  indicating  that 
LCMV-specific CTLs are not detectable in the LCMV-immune 
mice in bulk CTL assays with freshly isolated lymphocytes. 
Acute inf~ion of C57BL/6 mice (depleted of NK cells) with 
LCMV, VV, or PV resulted in the generation of cytotoxicity 
specific for the infecting virus. The level of cytotoxic activity 
was low at day 5 for LCMV and PV and reached high levels 
at day 7, whereas the level of cytotoxic activity for VV peaked 
earlier at day 5. The CTLs induced by each virus were virus- 
specific  and lysed cells  infected with different viruses only 
at very low levels and comparable to uninfected targets. How- 
ever, infection of LCMV-immune mice with W  or PV stimu- 
lated both challenge virus-specific  and LCMV-specific killing. 
In previous experiments, we showed that the phenotype of 
the virus-specific killer cells activated by VV or PV infection 
of LCMV-hyperimmuue mice were CD8 +, Thyl.2 +, asialo 
GM1- T  cells (12).  This indicated that memory CTL reac- 
tive against viral antigens from a previous heterologous viral 
infection were stimulated.  These LCMV-spedfic CTLs ap- 
peared by day 5 (Fig.  1) post infection and persisted at day 
7 (Fig.  2). 
Limiting Dilution Analysis of Spleen Leukocytes from LCMV- 
immune Mice Infected with a Second Virus.  LDAs were per- 
formed in order to determine at the donal level if this reacti- 
vation of memory CTLs to the first viral infection could re- 
late to possible remote cross-reactivities between the viruses. 
At day 7 after infection with FV, a splenic leukocyte precursor 
frequency (p/f) of 1/329 was derived against PV-infected target 
cells (Fig.  3 A). This value is in the same range as those ob- 
tained for LCMV precursor (p)CTL at day 7 post LCMV 
infection (6). During an acute PV infection pCTL against 
LCMV-infected targets were not detected (p/f <1/100,000) 
when leukocytes were stimulated in vitro against PV (Fig. 
3 A). However, in an LCMV-immune mouse acutely infected 
with PV for 7 d, splenic leukocytes stimulated with PV in 
vitro generated a p/f not only for PV-infected targets (1/212) 
but also for LCMV-infected targets  (1/7636)  (Fig.  3 B). 
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Figure  1.  Rtactivation  of  LCMV-specitic  memory  CTL after acute  (day 
5) infection with heteroiogous viruses. (A) C57BL/6 mice were injected 
intraperitoneaUy with various viruses, and CTL activity was assessed at 
day 5 of acute infection. (B) C57BL/6  mice  were inoculated  intraperitoneally 
with LCMV and injected 2-4 mo later with other viruses. CTL activity 
was then assessed. 
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Figure  2.  Reactivation ofl.CMV-speciiic memory CTL after acute (day 
7) infection with heterologous  viruses. (A) C57BL/6 mice were injected 
intraperitoneally with various viruses, and CTL activity was assessed. (B) 
C57BL/6 mice were inoculated with LCMV and inoculated 2-4 mo later 
with other viruses. CTL activity was then assessed. 
This was a consistent observation  both at days 5 and 7 
during an acute PV infection in an LCMV-immune mouse 
(Fig. 4, A and B). As expected at day 5 of an acute PV infec- 
tion, before the peak in PV-specific bulk CTL activity,  the 
p/f for PV-infected  targets was lower (1/1509) than at day 
7 (11280), which is near the peak of CTL activity.  This is 
the first time to our knowledge that p/s  for PV infection 
have been described, and although the mouse is not a normal 
host for PV it did generate p/f's very similar to those previ- 
ously observed for LCMV (6). The ratio of the p/f between 
PV and LCMV (stimulated  against PV) was 1:3 at day 5 and 
1:14 at day 7, suggesting a selection for the non-cross-reactive 
PV-specific  CTL as the PV infection progressed. 
I.CMV and PV are both arenaviruses and share some amino 
acid homology, but they can be considered beterologous viruses 
because their immunological cross-reactivity is quite remote 
(12,  24-26).  Reactivation  of I.CMV-specific  memory cells 
by the completely unrelated virus, W,  was also assessed in 
an LDA.  When an LCMV-immune C57BL/6  mouse was 
acutely infected with VV, and at day 5 of infection splenic 
leukocytes were stimulated in vitro with W-infected PECs, 
p/f)s both for W-  (1/2,402) and LCMV- (1/18,000) infected 
targets were derived (Hg. 5). These LDA results suggest that 
some form of cross-reactivity  may exist between these sero- 
logically unrelated viruses. 
Anti-CD8 Blocking of Cytotoxicity by Cross-reactive  pCTL. 
To determine whether the phenotype of the cross-reactive 
killer cells was that of CD8 + CTL and not, for example, 
NK cells, splenocytes from I,  CMV-immune mice infected for 
6 d with PV were treated with anti-CD8 plus complement 
before inclusion in an LDA stimulated against PV-infected 
PEC. In the control group, complement alone,  the p/f for 
PV kill was 1/950 and for I,CMV kill was 1/12,276, whereas 
in the CDS-depleted group there was a significant  decrease 
in p/s  to 1/20,755  and 1/60,653,  respectively.  This indi- 
cates that both types of killing were mediated by CD8 + T 
cells. To determine whether CD8 was needed in the killing 
process, anti-CD8 antibody was added directly to the cyto- 
toxicity assay of a similar LDA set up with untreated splenic 
lenkocytes.  The anti-CD8 antibody reduced the frequency 
of wells killing PV-infected  targets by •4-fold  and almost 
completely blocked lysis of the I,CMV-infected targets (120- 
fold)  (Fig.  6). 
Specificities of Short.term, PV-induced  pCTL Clones Derived 
from PV-infected  LCMV-immune Mic~  To further  confirm 
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Figure  3.  LCMVoimmune mice acutely in- 
fected with PV (day 7) generate in an LDA 
pCTL  to  LCMV when stimulated  in vitro 
with PV-h)_fect~ PEC. (A) Nonimmune mice. 
C57BL/6 mice were inoculated with PV in- 
traperitoneaUy, and LDA were set up at day 
7  of  infection.  (B)  I.CMV-immune  mice. 
C57BL/6 mice were inoculated intraperitone- 
ally with LCMV, and 1--4 mo later with PV. 
LDA were set up day 7 of acute I)V infection. 
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Figure 5.  LCMV-immune mice acutely infected with VV generate in 
an LDA pCTL to I.CMV when stimulated in vitro with W-infected PEC 
at day 5 of acute VV infection. 
whether the same clone of T ceils was recognizing targets 
infected with either of two viruses, LDAs were set up to pro- 
duce a large number of wells statistically  containing <0.5 
pCTL/well for either LCMV- or W-infected targets (i.e., 
monodonal wells). In these studies, as in Figs. 3 and 4, LCMV- 
immune mice were acutely infected with IV, and CTL clones 
were generated in LDA from spleen leukocytes stimulated 
against IV-infected PEC. Thus, the arising LCMV-specific 
clones should be cross-reactive with PC, as they were cuhi- 
rated with a PV stimulus. Statistical analyses by 2-tail Fisher's 
Exact Test in five different experiments demonstrated that 
the wells containing effector cells lyric to targets infected with 
each virus were not due to random associations  of distinct 
Iv-specific and LCMV-specific clones in the same well (Table 
1). This indicates that the same CTL done lysed both targets. 
At day 5 of the acute PV infection, "~23% (range 15-31%) 
of the wells containing Iv-specific pCTL clones were cross- 
reactive with LCMV at the level of cytotoxicity, lysing both 
PV- and LCMV-infected targets. Approximately 62% (range 
38-83%) of the wens containing LCMV-specific pCTL clones 
stimulated with PV-infected PEC were cytolytically cross- 
reactive with PV, lysing both Iv-infected and LCMV-infected 
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Figure 6.  Anti-CD8 blocks  lysis of (A) PV- 
infected targets and (B) LCMV-infected targets by 
pCTL from LCMV-immune mice acutely infected 
with PV (day 6) and stimulated in vitro with PV. Table  1.  Specificities  of Short-terra, PV-induced CTL Clones Derived  from PV-infected LCMV Immune Mice* 
Clone specifidties* 
LCMV  +  LCMV  +  LCMV  -  LCMV  - 
Expt.  no.  PV  +  PV  -  PV  +  PV  -  p  values 
No.  of clones 
1  5  1  11  55  0.001 
2  3  5  7  142  0.01 
3  3  1  17  51  0.06 
4  4  4  20  153  0.012 
5  4  10  14  68  0.3 
* C57BL mice were inoculated intraperitoneally with LCMV.  1-2 mo later these immune mice were inoculated with PC.  At 5 (Expts.  1-4) to 
7 (Expt. 5) d post infection spleen leukocytes from these mice were stimulated in vitro in LDA with PV-infected PECs, as described in Materials 
and Methods. 
* These data represent LDA wells with ~0.5 pCTL/well for both LCMV- and PV-infected targets when screened for CTL activity in a 10-h slCr 
release assay. 
S Statistical analysis of the distribution of clones by 2-tail Fisher's Exact test demonstrated the probability that the cross-reactive wells were not a 
random association of separate PV-specific and LCMV-specific clones. 
Table  2.  Cross-reactive  pCTL Elicited  from Immune Mice Infected with Only One  Virus 
Targets 
Immune  In Vitro 
status  stimulus  Expt.  KO  +  LCMV  KO  +  PV 
LCMV  PV  1"  pCTL*  50 (34-60)  6  (2-8) 
p/f  1/20,300  1/198,000 
2s  pCTL  8  (2-14)  12  (2-22) 
p/f  1/135,000  1/81,700 
PV  LCMV  1  pCTL  2  (1-4)  2  (2-4) 
p/f  1/473,000  1/377,000 
LCMV  LCMV  1  pCTL  972  (726-1,218)  76  (38-116) 
p/f  1/1,028  1/13,000 
2  pCTL  366  (226-508)  34  (19-56) 
p/f  1/2,726  1/30,187 
PV  PV  1  pCTL  10  (4-22)  1,062  (690-1,434) 
p/f  1/104,000  1/942 
LCMV  PECII  1  pCTL  <0.25  <0.25 
p/f  <1/4,000,000  (1/4,000,000 
PV  PEC  1  pCTL  (0.5  (0.5 
p/f  (1/2,000,000  (1/2,000,000 
Naive~  PEC  1  pCTL  0.5  0.6 
p/f  1/2,700,000  1/7,000,000 
Naive  LCMV  1  pCTL  1.7  0.8 
p/f  1/562,000  1/1,300,000 
Naive  PV  1  pCTL  0.3  0.6 
p/f  1/3,500,000  1/1,800,000 
* In all experiments designated Expt.  1 the LDA was harvested after 8 d in culture (stimulated twice with virus-infected PECs, at day 0 and day 4). 
* pCTL means the number of pCTL/106  splenic leukocytes. 
S In all experiments designated Expt. 2 the LDA was harvested after 5 d in culture (stimulated only once with virus-infected PECs, at day 0). 
fl PEC are uninfected PECs used as antigen presenting cells. 
I Uninfected mice. 
1938  Cross-reactive CTLs between Heterologous Viruses targets.  However, a significant  number of clones (38%) in 
each of these experiments lysed only the LCMV-infected 
targets. This is an unexpected observation, since these clones 
were stimulated to grow by FV-infected PEC. This observa- 
tion could be explained by affinity differences or ff the cross- 
reactive stringency for induction of proliferation of the memory 
l.CMV-specific pCTL is lower than that for target recogni- 
tion and lysis. Alternatively, differences in antigen presenta- 
tion (6,  27)  or adhesion molecules (28,  29)  between the 
stimulating PEC and the CTL assay targets (KO cells) might 
account for clones cytolytically specific only for LCMV. 
Cross-reactive  pCTL Elicited  from Immune Mice Infected with 
Only One Virus.  We questioned whether cross-reactive CTL 
could be generated from splenocytes of immune mice which 
had not been challenged in vivo with a second virus. Spleno- 
cytes from LCMV-immune mice not receiving acute PV in- 
fection when stimulated in vitro with heterologous virus (PV) 
generated p/f's to both LCMV- (1/135,000)  and PV-infected 
(1/81,600)  targets (Table 2). PV-immune splenocytes stimu- 
hted in vitro with the heterologous virus, LCMV, also gener- 
ated p/fs to both targets (LCMV-infected targets, 1/473,000; 
PV-infected targets,  1/377,000) but at a lower level than ob- 
served with the I.CMV-immune splenocytes. VV-immune 
splenocytes when stimulated with LCMV in vitro generated 
pCTL to both I,CMV- and VV-infected targets, but the p/f 
curves were nonlinear (estimated p/f's: LCMV-infected targets, 
1/341,000;  VV-infected targets,  1/177,000)  (not tabulated). 
Splenocytes from an LCMV-immune mouse when stimu- 
lated in vitro with homologous LCMV generated a low but 
consistent p/f to PC-infected targets (1/13,000;  1/30,000) 
(Table 2). A similar observation ofpCTL to LCMV-irrfected 
targets was  made with PC-immune (1/104,000)  and VV- 
immune (1/321,000)  (not tabulated) animals,  as they were 
able to generate a low p/f to LCMV-infected targets when 
stimulated in vitro with the initial infecting virus. It should 
be noted that the p/f for LCMV- and FV-immune mice stimu- 
hted with uninfected PECs or for unin~ted naive mice stimu- 
lated with I.CMV- or PV-infected PECs was <1/106. 
pCTL in LCMV-immune Splenoo/tes  Stimulated  In Vitro with 
LCMV NP Pept/d~  To determine whether the cross-reactivity 
between virus-infected cells was due to recognition of viral 
peptides, as opposed to a common virus-induced cellular an- 
tigen, we examined the p/f to LCMV- and PV-infected targets 
using LCMV-immune splenocytes stimulated in vitro with 
LCMV NP peptide. These experiments were done in the pres- 
ence of IL-7, as this cytokine has recently been demonstrated 
to enhance the stimulation of virus-specific CTL by peptide 
alone in naive uninfected mice (30, 31). Under these condi- 
tions, not only was an appropriate p/f to LCMV-infected 
targets (1/10,000;  1/24,000) generated but also a significant 
p/f to w-infected targets (1/71,000;  1/100,000) (Fig. 7). NP- 
specific CTL compose ,x,20% of the pCTL to LCMV in an 
LCMV-immune C57BL/6 mouse. The usual LCMV p/f in 
an LCMV-immune C57BL/6 mouse is in our experimental 
system 1/1000-1/2000. Therefore, an LCMV-specific p/f of 
1/10,000-1/20,000  would be  appropriate  in  an  LCMV- 
immune C57BL/6 mouse stimulated with NP peptide. Al- 
though 1/71,000 (1/100,000)  is a low p/f, it is nonethdess 
significant, as stimulation of naive uninfected mice or LCMV- 
immune mice with uninfected PECs resulted in p/f's to ei- 
ther LCMV- or FV-infected targets of <1/10  ~. These results 
support the concept that viral peptides are involved in the 
recognition process by cross-reactive T cells between different 
viruses. 
Priming of CTL Response to Subsequent Acute Viral Infec- 
tions by Previous Viral Infection.  At both day 5 and day 7 of 
acute PV infection there was a reproducibly enhanced pCTL 
to challenge virus (PV) in LCMV-immune mice as compared 
(3c 
2 
z 
0.01 
￿9  KO+PV 
'\~  ...............  P/F=I/IO0,O00 
"""'"',,,  KO+PV  .........  '~,,\  ~  P/F=1/71,000 
"'~,  '"",  ',  ~  KO+LCM 
'  KO+LCMV 
,  P/F=I/IO,O00 
i  I  I  I  I  I  I  L 
10  20  30  40  50  60  70  80  90 
CELLS/WELL X 103 
1939  Selin et al. 
100 
Figure 7.  LCMV-immune len- 
kocytes stimulated in vitro with 
the immunodomln~nt  LCMV NP 
peptide  in the presence of IL,7 
in an LDA. C57BL/6 mice were 
inoculated with LCMV, and 1-4 
mo later their spleens were har- 
vested.  Splenic lenkocytes were 
then set up in LDA stimulated 
in vitro with LCMV NP peptide- 
sensitized PECs, in the presence 
of 15 U/ml of IL,7. SlCr release 
assays were  done  against  both 
LCMV- and FV-infected targets. 
Dotted  line  represents  the  p/fs 
curves of Expt.  1 and solid llne 
of Expt.  2.  In Expt.  1  only a 
two-way  split-well analysis was 
done, whereas in Expt. 2 a three- 
way split-weU analysis was done. 
This may help  to  explain why 
the p/f  in  Expt.  1  is  slightly 
higher than in Expt. 2. Table  3.  Increased  pCTL to Heterologous Virus after Infection of Immune Mice 
Expt.  Day*  Acute PV* 
Viral infections 
LCMV-immune  +  acute pVS 
1  5  pCTLU  288 (220-354) 
p/f  1/4,377 
2  7  pCTL  3,040  (2,400-3,650) 
p/f  1/329 
3  7  pCTL  1,139 (752-1,527) 
p/f  1/878 
4  7  pCTL  532 (283-781) 
p/f  1/1,880 
5  5  pCTL  637 (410-864) 
p/f  1/1,571 
Acute LCMV  1 
6  7  pCTL  3,816 (2,688-4,950) 
p/f  1/262 
502 (324-682) 
1/1,990 
4,716  (3,676-5,748) 
1/212 
1,901 (1,366-2,439) 
1/526 
1,309 (845-1,773) 
1/764 
2,967 (2,066-3,861) 
1/337 
PV-immune  +  acute LCMV*" 
7  7 
Acute LCMV 
6,666 (4,546-8,772) 
1/150 
VV-immune  +  acute LCMVt* 
pCTL  3,816 (2,688-4,950)  6,896 (4,310-9,524) 
p/f  1/262  1/145 
* Day of acute infection  with second virus. 
* C57BL mice acutely infected with PV. 
$ C57BL mice were inoculated with LCMV and 1-4 mo later acutely infected with PV. 
II pCTL are the number of precursor CTL/106 splenic leukocytes. 
￿82  C57BL mice were acutely infected with LCMV. 
"" C57BL mice were inoculated with PV and 1-4 mo later acutely infected with LCMV. 
t* C57BL mice were inoculated with VV and 1-4 mo later acutely infected with LCMV. 
with nonimmune mice when splenic leukocytes were stimu- 
lated in vitro with PV (Table 3). Similarly, in individual ex- 
periments higher pCTL to LCMV were generated after LCMV 
infection of PV-immune or VV-immune mice than after in- 
fection of nonimmune mice (Table 3). These results indicate 
that a prior viral infection can prime a CTL response to a 
heterologous virus in a subsequent infection. 
Discussion 
This study shows that memory CTL specific to one virus 
contribute to the primary polyclonal CTL response during 
infection with a second heterologous virus. This reactivation 
of memory CTL by heterologous viruses could be due to 
either (a) a nonspecific stimulation of memory cells, particu- 
larly the blast-sized IL-2R-bearing cells, with lymphokines 
generated during the T cell response to the heterologous virus 
infection; or (b) a specific stimulation of memory cells due 
to the fact that they cross-reacted, albeit possibly at a remote 
level, with MHC-presented heterologous viral or virus-induced 
cellular peptides. Enhanced expression of adhesion molecules 
and IL-2R by memory cells might make them particularly 
sensitive to stimulation by a low affinity T cell antigen. Our 
data have not ruled out the possibility of substantial levels 
of nonspecific stimulation, but they do convincingly support 
the hypothesis of cross-reactivity. This type of cross-reactivity 
was demonstrated in a number of ways at the clonal level 
using LDA analyses. (a)  Splenic leukocytes from LCMV- 
immune mice acutely infected with PV or W  generated pCTL 
to LCMV when stimulated in vitro with PEC's infected only 
with the second virus but not with uninfected PEC's.  (b) 
LCMV-immune splenocytes stimulated in vitro with PV or 
VV demonstrated a low but significant CTL p/f to the het- 
erologous viruses, and splenocytes from PV- or VV-immune 
mice when stimulated in vitro against LCMV generated a 
low but significant p/f to LCMV. (c) LCMV-immune spleno- 
cytes stimulated in vitro with an immunodominant LCMV 
peptide generated a p/f to PV. (d) In short-term LDA cul- 
tures using split-well analyses, CTL clones cross-reactive be- 
tween LCMV and PV were observed in splenic leukocytes 
1940  Cross-reactive  CTLs between Heterologous  Viruses from LCMV-immune mice acutdy infected with PV. It should 
be noted that W  and PV were propagated in different calls 
(L-929) than was LCMV (BHK21), and the fact that the NP- 
peptide preparation was able to stimulate cross-reactive  pCTL 
in LCMV-immune mice makes it unlikely that a cellular con- 
taminant was the source of the cross-reactivity. In addition, 
plaque purified stocks of PV and LCMV were tested and found 
to show the same type of cross-reactivity. 
Analyses of the relationships  between different  viruses 
and viral proteins have focused on homologies between linear 
amino add sequences,  but cross-reactivities  at the level  of T cell 
recognition may not be dependent on a conserved linear 
sequence of several amino adds. Cross-reactivity  in the rec- 
ognition of unrelated viral peptides by T cell lines and clones 
has been previously reported (1-4).  Anderson et al. (1) de- 
scribed an influenza A NP-specific CTL line which could 
lyse not only NP peptide-sensitized targets but also targets 
sensitized with two different influenza A basic polymerase 
2 (PB2) peptides. Shimojo et al. (2) described cross-reactive 
recognition of a human rotavims VP4 peptide by an HLA-A2.1- 
restricted  CTL line induced by a very dissimilar influenza 
A matrix peptide. Kuwano et al. (3) demonstrated recogni- 
tion of two distinct influenza peptides from HA and NS1 
by an H-2Ka-restricted influenza-specific CTL clone. Re- 
cently Kulkarni et al. (4) demonstrated that immunization 
of mice with a W  recombinant of the M2 protein of respira- 
tory syncytial virus induced CTL that lysed in a cross-reactive 
manner targets sensitized with either of two peptides derived 
from different nonoverlapping regions of the same M2 pro- 
tein. Analyses of the amino acid sequences of the peptides 
used in these experiments have showed relatively little ho- 
mology, and the cross-reactive epitope was often of lower 
affinity, as defined by the fact that it required much higher 
concentrations of the peptides  to sensitize the target. 
Many of the cross-reactive CTL between heterologous 
viruses in our experiments may be of low affinity to at least 
one of the viruses. This is supported by the observation that 
anti-CD8 was more efficient at blocking lysis of the I.CMV- 
infected target rather than the PV-infected target in LCMV- 
immune mice acutely infected with PV. It has been reported 
that blocking with anti-CD8 is one method to differentiate 
high affinity and low affinity CTL clones (32). These puta- 
tively low affinity cross-reactive interactions may be best ob- 
served once a large memory  pool has been defined and during 
an acute infection when activating lymphokines have increased 
the CTL expression of ancillary adhesion molecules that may 
enhance the ability of a low affinity interaction to stimulate 
a T  cell expansion. 
It is not surprising that processed peptides from different 
proteins  could cross-react,  as the presented  peptides  must 
comply with the sequence motif for the presenting MHC 
molecule and therefore may share similar amino acids in two 
or three critical positions of the peptide nonamer. Numerous 
virus-spedfic clones recognizing noninfected cells expressing 
different alleles of class I molecules have also been identified. 
We have shown high frequencies of LCMV-specific short- 
term clones in H-2  b mice that cross-reacted with various 
different class I MHC alleles, including H-2  k or H-2  d (6). 
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HSV- (33) and Moloney-spedfic (34) H-2Kb-restricted CTL 
generated after secondary in vitro stimulation recognize unin- 
fected cells expressing K ~  molecules. 
LCMV and PV are both arenaviruses, and they do share 
considerable amino acid homology, but their serological  cross- 
reactivity  is nevertheless quite remote. Antisera do not cross- 
neutralize, although there is a report of some cross-reactive 
complement-fixing  antibodies to the viral nucleoprotein (24) 
and one monodonal antibody directed against  a common 
arenavirus glycoprotein  (GP-C)  sequence (25). They share 
no 9 amino acid sequence overlapping  any of the defined 
LCMV T cell immunodominant peptides, and, in fact, acute 
PV infection does not generate CTL that can in bulk assays 
lyse LCMV infected targets,  and vice versa (Figs. 1 and 2; 
reference 12). Our results, however, suggest that some form 
of CTL cross-reactivity may exist between these two heter- 
ologous viruses. 
Screening of the published  PV NP amino acid sequence 
revealed at the site of homology  with the LCMV NP peptide 
a nonamer with five amino adds in common with the LCMV 
H-2b-restricted immunodominant NP LCMV peptide (LCMV 
-- FQPQNGNFI (5); PV = YQPDTGNYI). However, the 
PV sequence does not have the major fifth position asparagine 
anchoring amino acid required for binding to the H-2D  b 
motif (5), and we have not been able to show that the syn- 
thesized PV peptide can sensitize targets to CTL induced by 
either PV or I.CMV. This supports the concept that, although 
LCMV and PV have some amino acid homology, they are 
heterologous viruses in regards to CTL recognition and do 
not have similar immunodominant epitopes. The immuno- 
dominant epitopes for PV are as yet undefined, and in fact, 
a search for CTL epitopes on the PV nucleoprotein was un- 
successful (35). These results  also indicate  that it may be 
difficult to predict which viral peptides will be cross-reactive 
at least until the TCR binding motifs for various viral pep- 
tides can be identified. Nevertheless, our data dearly argue 
that at the level of CTL there is definitely cross-reactivity 
between LCMV and PV and probably cross-reactivity  between 
LCMV and W, both unexpected findings, as cross-reactivities 
between these viruses are not seen in conventional hulk assays 
using CTL from mice infected with a single virus. 
The implication of these analyses  is that, at the T cell level, 
there may be a great deal of immunological cross-reactivity 
between serologically  unrelated infectious agents, and by virtue 
of this proposed remote T cell cross-reactivity, memory T 
cells from a previous unrelated infection may be reactivated 
and contribute to the primary response of a putatively un- 
related infectious agent. Jones et al. have demonstrated that 
an MHC-restricted T  cell proliferative response to Plasmo- 
dium fakiparum malaria antigens could occur in donors not 
immune to malaria. However, this response required the pres- 
ence of memory T  cells (UCHL1 + cells), suggesting that 
this cross-reactive response was due to epitopes shared be- 
tween P. fakiparum and some other common immunogens 
that  induced a  memory T  cell pool  (36). Cross-reactive 
memory T  cells may account for the high frequency of T 
cells expressing mRNA for activating lymphokines (IFN-% 
IL-2) at day 3 early in viral infection long before the primary virus-specific pCTL could have expanded to detectable levels 
from naive mice (37).  There is evidence in the alloantigen 
system that naive and memory T  cell subsets differ in their 
ability to synthesize and respond to a variety of cytokines 
and that each subset can produce cytokines that amplify the 
response of the other subset (7). Both subsets appear to be 
activated to the same extent by alloantigen,  and it has been 
suggested that they synergize in initiating potent responses 
against  transplanted  allografts. 
These data together suggest that prior immunity to one 
virus might provide some level of protective natural immu- 
nity to an unrelated infectious agent.  Consistent with this 
concept is our previous work showing that VV replication 
in LCMV-immune mice was reduced by ~10-fold (38), and 
we have recently found a similar  10-fold reduction of PV titers 
in  LCMV-immune  mice,  and  splenocytes  from  LCMV- 
immune mice when transferred  to nonimmune recipients  (one 
splenic equivalent/mouse) conferred a similar degree of resis- 
tance to FV (data not shown). The mechanism for this resis- 
tance to heterologous virus infection has not been clarified, 
but may involve cross-reactive CD8 + cells,  as CD8 + CTL 
are major regulators of infection for each of these viruses (26, 
39).  It is equally feasible that  cross-reactivity exists at the 
CD4 level,  and these cells could provide resistance to infec- 
tion via the secretion of cytokines. These results do, how- 
ever, suggest that prior immunity to one virus enhances the 
immune  system's ability  to  handle  future  viral  infections, 
thereby contributing  to natural  resistance. 
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